Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster revers...
Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
This randomized, double-blind trial evaluated sugammadex-mediated recovery time from rocuronium- or vecuronium-induced moderate (M-) or deep (D-) neuromuscular block in morbidly obese adults dosed by actual (ABW) or ideal body weight (IBW).
Adults with BMI ≥40 kg/m
were randomized to 1 of 5 groups: M-neuromuscular block, sugammadex 2 mg/kg AB...
Alternative Titles
Full title
Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_034f1c5e7f9e4b51bd8ba45a738f41a8
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_034f1c5e7f9e4b51bd8ba45a738f41a8
Other Identifiers
ISSN
1471-2253
E-ISSN
1471-2253
DOI
10.1186/s12871-021-01278-w
